In a bold move, Russell Vought has initiated mass layoffs of federal workers as the government shutdown drags into its 11th day. With Congress at an impasse, will Democrats cave or will more workers face job loss?
In a shocking move, the federal government has begun layoffs affecting thousands of employees due to the ongoing shutdown. With various agencies impacted, including Education and Commerce, the unions are pushing back against the legality of these actions.
In a significant legal ruling, a federal appeals court has decided that National Guard troops in Illinois will remain under federal control but cannot be deployed while the appeals process unfolds. This decision is part of an ongoing legal battle between the Trump administration and state officials over troop deployment amid protests.
In a drastic move, the White House has initiated layoffs affecting over 4,000 federal employees as part of its reduction-in-force strategy during the ongoing government shutdown. Key departments like Treasury and Health and Human Services are hit hardest, raising concerns about public services.
In a shocking move, the CDC has laid off key leaders of the federal measles response team just as the U.S. faces a record number of measles cases. Experts warn this could jeopardize public health and safety.
Former national security adviser John Bolton is on the brink of federal charges related to classified materials. Will he face indictment next week? Discover the shocking details of this high-profile investigation.
In a surprising conversation, Trump spoke with Nobel laureate Maria Corina Machado, who received the Peace Prize for her democratic efforts in Venezuela. The discussion comes amid Trump's own aspirations for the award and political tensions.
MIT researchers have developed a groundbreaking method for gene editing that significantly reduces errors, making gene therapy safer and more effective for treating genetic diseases. This innovative approach promises a future of precise genomic alterations with fewer side effects.
In a major move against high prescription costs, AstraZeneca has agreed to sell its drugs at a discount through Medicaid, marking a significant win for the Trump administration's healthcare initiative.
AstraZeneca partners with the Trump administration to offer drastically lower drug prices through Medicaid and the upcoming TrumpRx platform, aiming to make medications more accessible to consumers.
